Two-Year Results of a Multicenter Prospective Observational Study of the Zenith Spiral-Z Limb Deployed in the External Iliac Artery During Endovascular Aneurysm Repair.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 09 2020
Historique:
pubmed: 8 8 2020
medline: 14 10 2021
entrez: 8 8 2020
Statut: ppublish

Résumé

Limited data is available on the use of a polyester graft limb with a helical stent configuration deployed in the external iliac artery (EIA) during endovascular aneurysm repair (EVAR), so we prospectively analyzed the efficacy of the Zenith Spiral-Z limb deployed in the EIA.Methods and Results:Patients undergoing EVAR using a Zenith stent-graft and Spiral-Z limb deployed in the EIA were prospectively registered in 24 Japanese institutions from June 2017 to November 2017. In total, 65 patients (74 limbs) (mean age: 77.1±8.0 years, 87.7% men, mean abdominal aortic aneurysm (AAA) diameter: 51.9±7.2 mm, mean iliac artery aneurysm (IAA) diameter: 38.3±10.0 mm) were registered and followed up. The most common reason for deployment in the EIA was a common IAA (43 limbs, 58.1%), and 8 limbs (10.8%) had a bare nitinol stent placed at the Spiral-Z limb. A total of 61 patients (70 limbs) completed a 24-month follow-up. There were 2 Spiral-Z limb stenoses and 1 occlusion, leading to a primary patency of 95.5% and a secondary patency of 100%, at 24 months. Buttock claudication occurred in 24.3% of the limbs treated at 1 month but decreased to 4.3% at 24 months. Our multicenter prospective study showed that Spiral-Z limb deployed in the EIA was associated with satisfactory results and seems to be a durable option, even in the era of iliac branch devices.

Sections du résumé

BACKGROUND
Limited data is available on the use of a polyester graft limb with a helical stent configuration deployed in the external iliac artery (EIA) during endovascular aneurysm repair (EVAR), so we prospectively analyzed the efficacy of the Zenith Spiral-Z limb deployed in the EIA.Methods and Results:Patients undergoing EVAR using a Zenith stent-graft and Spiral-Z limb deployed in the EIA were prospectively registered in 24 Japanese institutions from June 2017 to November 2017. In total, 65 patients (74 limbs) (mean age: 77.1±8.0 years, 87.7% men, mean abdominal aortic aneurysm (AAA) diameter: 51.9±7.2 mm, mean iliac artery aneurysm (IAA) diameter: 38.3±10.0 mm) were registered and followed up. The most common reason for deployment in the EIA was a common IAA (43 limbs, 58.1%), and 8 limbs (10.8%) had a bare nitinol stent placed at the Spiral-Z limb. A total of 61 patients (70 limbs) completed a 24-month follow-up. There were 2 Spiral-Z limb stenoses and 1 occlusion, leading to a primary patency of 95.5% and a secondary patency of 100%, at 24 months. Buttock claudication occurred in 24.3% of the limbs treated at 1 month but decreased to 4.3% at 24 months.
CONCLUSIONS
Our multicenter prospective study showed that Spiral-Z limb deployed in the EIA was associated with satisfactory results and seems to be a durable option, even in the era of iliac branch devices.

Identifiants

pubmed: 32759542
doi: 10.1253/circj.CJ-20-0195
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1764-1770

Auteurs

Naoki Fujimura (N)

Division of Vascular Surgery, Saiseikai Central Hospital.

Tomohiro Imazuru (T)

Department of Cardiovascular Surgery, Teikyo University Hospital.

Hitoshi Matsumura (H)

Department of Cardiovascular Surgery, Fukuoka University School of Medicine.

Tsuyoshi Shibata (T)

Department of Cardiovascular Surgery, Hakodate Municipal Hospital.

Tadashi Furuyama (T)

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University.

Kenjiro Kaneko (K)

Department of Vascular Surgery, Shin-yurigaoka General Hospital.

Hidetoshi Uchiyama (H)

Department of Vascular Surgery, Tsuchiura Kyodo General Hospital.

Noriyasu Morikage (N)

Department of Vascular Surgery, Yamaguchi University.

Takayuki Uchida (T)

Department of Cardiovascular Surgery, Iiduka Hospital.

Eiichi Teshima (E)

Department of Cardiovascular Surgery, Fukuoka Wajiro Hospital.

Terutoshi Yamaoka (T)

Department of Vascular Surgery, Matsuyama Red Cross Hospital.

Hiroshi Masuhara (H)

Department of Cardiovascular Surgery, Toho University Omori Medical Center.

Hideki Ueda (H)

Department of Cardiovascular Surgery, Chiba University.

Mamoru Arakawa (M)

Department of Cardiovascular Surgery, Nerima Mitsugaoka Hospital.

Togo Norimatsu (T)

Department of Vascular Surgery, Sakakibara Memorial Hospital.

Hideaki Obara (H)

Department of Surgery, Keio University School of Medicine.

Seiji Onitsuka (S)

Department of Surgery, Kurume University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH